Use of teicoplanin in preterm neonates with staphylococcal late-onset neonatal sepsis

被引:8
|
作者
Degraeuwe, PLJ
Beuman, GH
van Tiel, FH
Maertzdorf, WJ
Blanco, CE
机构
[1] Univ Hosp Maastricht, Dept Paediat, NL-6202 AZ Maastricht, Netherlands
[2] Univ Hosp Maastricht, Dept Clin Pharm, NL-6202 AZ Maastricht, Netherlands
[3] Univ Hosp Maastricht, Dept Clin Microbiol, NL-6202 AZ Maastricht, Netherlands
来源
BIOLOGY OF THE NEONATE | 1998年 / 73卷 / 05期
关键词
teicoplanin; pharmacology; adverse effects; Gram-positive bacterial infections; drug therapy;
D O I
10.1159/000013987
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: To study the clinical pharmacology of teicoplanin in babies admitted to a newborn intensive care unit, by monitoring serum levels, efficacy and potential side effects. Methods: An open, nonrandomized descriptive study was performed in the neonatal intensive and high care unit of the University Hospital Maastricht, The Neterlands. Twenty-three preterm neonates, gestational age ranging from 26 to 32 weeks (median 28.4 weeks), postnatal age from 5 to 47 days, and birth weight from 570 to 1,740 g, presenting with (suspected) late onset septicemia, were studied. Of 21 culture-proven septicemias, 20 were caused by staphylococci. The teicoplanin loading dose was 15 mg/kg i.v., followed by a maintenance dose of 8 mg/kg every 24 h. Intravenous gentamicin was also administered pending blood culture. Serum teicoplanin concentrations were measured by fluorescence polarization immunoassay. Clinical and microbiological cure/failure rates were determined and possible side effects were monitored. Results: The study of individual pharmacokinetics during multiple-dose intravenous infusions was rendered impossible by apparently inaccurate dosing. Peak (30 min after end of the infusion) and trough teicoplanin levels were stable throughout the study and averaged 27.8 (interquartile range 23.7-32.9) and 12.3 (interquartile range 9.1-16.8) mg/l, respectively. The microbiological and clinical cure rates were 90% in gram-positive septicemia. There was no apparent toxicity. Conclusions: Inaccurate drug administration was a problem in this study, making a multidose pharmacokinetic study impossible. It is possible that inaccurate drug administration and not current dosage guidelines yielded trough levels below 10 mg/l in 57 (32%) of 176 instances. This pharmaceutical aspect clearly warrants further study. However, microbiological and clinical cure rates were high in gram-positive septicemias, No side effects attributable to teicoplanin therapy were encountered.
引用
收藏
页码:287 / 294
页数:8
相关论文
共 50 条
  • [21] Late-onset sepsis due to urinary tract infection in very preterm neonates is not uncommon
    Alexander B. Mohseny
    Veerle van Velze
    Sylke J. Steggerda
    Vivianne E. H. J. Smits-Wintjens
    Vincent Bekker
    Enrico Lopriore
    European Journal of Pediatrics, 2018, 177 : 33 - 38
  • [22] 519 Predictive Value of Clinical Signs in Late-Onset Sepsis (LOS) in Preterm Neonates
    J Bekhof
    I Van Straaten
    J Kok
    Pediatric Research, 2010, 68 : 265 - 265
  • [23] Late-onset neonatal sepsis: recent developments
    Dong, Ying
    Speer, Christian P.
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2015, 100 (03): : F257 - F263
  • [24] Antibiotic regimens for late-onset neonatal sepsis
    Korang, Steven Kwasi
    Safi, Sanam
    Nava, Chiara
    Greisen, Gorm
    Gupta, Munish
    Lausten-Thomsen, Ulrik
    Jakobsen, Janus C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (05):
  • [25] Late-onset neonatal sepsis in Suzhou, China
    Tao Pan
    Qiujiao Zhu
    Pei Li
    Jun Hua
    Xing Feng
    BMC Pediatrics, 20
  • [26] Late-onset neonatal sepsis in Suzhou, China
    Pan, Tao
    Zhu, Qiujiao
    Li, Pei
    Hua, Jun
    Feng, Xing
    BMC PEDIATRICS, 2020, 20 (01)
  • [27] Use of the Complete Blood Cell Count in Late-onset Neonatal Sepsis
    Hornik, Christoph P.
    Benjamin, Daniel K.
    Becker, Kristian C.
    Benjamin, Daniel K., Jr.
    Li, Jennifer
    Clark, Reese H.
    Cohen-Wolkowiez, Michael
    Smith, P. Brian
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (08) : 803 - 807
  • [28] Evaluation of procalcitonin as a marker in late-onset sepsis in neonates
    Jacquot, A.
    Labaune, J. M.
    Baum, T. P.
    Picaud, J. C.
    Putet, G.
    ACTA PAEDIATRICA, 2007, 96 : 155 - 155
  • [29] Late-onset sepsis due to Salmonella Typhi in a preterm infant in a French neonatal unit
    Walser, S.
    El Moussawi, F.
    Sire, J. M.
    Do Cao, J.
    Boileau, P.
    Letouzey, M.
    ARCHIVES DE PEDIATRIE, 2021, 28 (01): : 93 - 95
  • [30] Late-onset Streptococcus pasteurianus sepsis in a preterm baby in a neonatal intensive care unit
    Tarakci, Nuriye
    Dagi, Hatice Turk
    Ugur, Ayse Ruveyda
    Tuncer, Inci
    Tastekin, Ayhan
    TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2014, 49 (02): : 157 - 159